These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32942038)

  • 61. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.
    Michielan A; D'Incà R
    Mediators Inflamm; 2015; 2015():628157. PubMed ID: 26582965
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inflammatory bowel disease and the apical junctional complex.
    Bruewer M; Samarin S; Nusrat A
    Ann N Y Acad Sci; 2006 Aug; 1072():242-52. PubMed ID: 17057204
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vitamin D Deficiency in the Gulf Cooperation Council: Exploring the Triad of Genetic Predisposition, the Gut Microbiome and the Immune System.
    Singh P; Kumar M; Al Khodor S
    Front Immunol; 2019; 10():1042. PubMed ID: 31134092
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation.
    Assa A; Vong L; Pinnell LJ; Avitzur N; Johnson-Henry KC; Sherman PM
    J Infect Dis; 2014 Oct; 210(8):1296-305. PubMed ID: 24755435
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.
    Awad WA; Hess C; Hess M
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208612
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.
    Celiberto LS; Graef FA; Healey GR; Bosman ES; Jacobson K; Sly LM; Vallance BA
    Immunology; 2018 Sep; 155(1):36-52. PubMed ID: 29693729
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vitamin D Signaling in Gastro-Rheumatology: From Immuno-Modulation to Potential Clinical Applications.
    Pagnini C; Picchianti-Diamanti A; Bruzzese V; Lorenzetti R; Luchetti MM; Martin LSM; Pica R; Scolieri P; Scribano ML; Zampaletta C; Chimenti MS; Lagana B
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Associations between inflammatory bowel diseases and vitamin D.
    Barbalho SM; Goulart RA; Gasparini RG
    Crit Rev Food Sci Nutr; 2019; 59(8):1347-1356. PubMed ID: 29236523
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vitamin D: new roles and therapeutic potential in inflammatory bowel disease.
    Raftery T; O'Morain CA; O'Sullivan M
    Curr Drug Metab; 2012 Nov; 13(9):1294-302. PubMed ID: 22493989
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Probiotics and inflammatory bowel diseases.
    Bai AP; Ouyang Q
    Postgrad Med J; 2006 Jun; 82(968):376-82. PubMed ID: 16754706
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The endocrine vitamin D system in the gut.
    Barbáchano A; Fernández-Barral A; Ferrer-Mayorga G; Costales-Carrera A; Larriba MJ; Muñoz A
    Mol Cell Endocrinol; 2017 Sep; 453():79-87. PubMed ID: 27913273
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pathophysiology of IBD associated diarrhea.
    Anbazhagan AN; Priyamvada S; Alrefai WA; Dudeja PK
    Tissue Barriers; 2018; 6(2):e1463897. PubMed ID: 29737913
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cross-talk between intestinal epithelial cells and immune cells in inflammatory bowel disease.
    Al-Ghadban S; Kaissi S; Homaidan FR; Naim HY; El-Sabban ME
    Sci Rep; 2016 Jul; 6():29783. PubMed ID: 27417573
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases.
    Shang M; Sun J
    Curr Med Chem; 2017; 24(9):876-887. PubMed ID: 27915988
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation.
    Mehta M; Ahmed S; Dryden G
    Innate Immun; 2017 Aug; 23(6):497-505. PubMed ID: 28770665
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vitamin D in Inflammatory Bowel Disease: Biological, Clinical and Therapeutic Aspects.
    Olmedo-Martín RV; González-Molero I; Olveira G; Amo-Trillo V; Jiménez-Pérez M
    Curr Drug Metab; 2019; 20(5):390-398. PubMed ID: 31109269
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impaired Autophagy in Intestinal Epithelial Cells Alters Gut Microbiota and Host Immune Responses.
    Yang L; Liu C; Zhao W; He C; Ding J; Dai R; Xu K; Xiao L; Luo L; Liu S; Li W; Meng H
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006408
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association between Serum 25 (OH) Vitamin D Concentrations and Inflammatory Bowel Diseases (IBDs) Activity.
    Hassan V; Hassan S; Seyed-Javad P; Ahmad K; Asieh H; Maryam S; Farid F; Siavash A
    Med J Malaysia; 2013; 68(1):34-8. PubMed ID: 23466764
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Roles of intestinal epithelial cells in the maintenance of gut homeostasis.
    Okumura R; Takeda K
    Exp Mol Med; 2017 May; 49(5):e338. PubMed ID: 28546564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.